glp-1 side effects depression GLP-1RA Essentials in Gastroenterology: Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment Do GLP-1 Injections Make You

In summary, GLP-1RAs reduce ASCVD risk in individuals with T2D, and semaglutide reduces ASCVD in people with obesity, with consistent reductions in MACE observed across multiple CVOTs

According to the existing data results, the clinical effect of these new drugs in research is better than that of simple GLP-1 agonists in terms of hypoglycemia and weight loss

SGLT-2 inhibitors: the gap seems to be leveling off

Those interested in potential neuroprotective or anti-inflammatory benefits

Tronieri reports receiving an investigator-initiated grant, on behalf of the University of Pennsylvania, from Novo Nordisk and receiving consulting fees from Currax Pharmaceuticals, LLC

doi:10.1016/j.peptides.2013.01.014